Article Details

NurExone Biologic Inc. to Begin Trading on TSX Venture Exchange and Retains Market Maker

Retrieved on: 2022-06-22 12:15:45

Tags for this article:

Click the tags to see associated articles and topics

NurExone Biologic Inc. to Begin Trading on TSX Venture Exchange and Retains Market Maker. View article details on hiswai:

Excerpt

NurExone is a pharmaceutical company developing a biological extracellular vesicles (EV)-based technology drug platform. This is a unique advanced ...

Article found on: news.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up